ST
FOLD

Spot Trading’s Amicus Therapeutics FOLD Stock Holding History

Spot Trading’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$235K Buy
15,578
+5,686
+57% +$75.2K ﹤0.01% 2135
2017
Q2 		$100K Buy
+9,892
New +$79.6K ﹤0.01% 2590
2017
Q1 		– Sell
-11,649
Closed -$73.7K – 3052
2016
Q4 		$58K Sell
11,649
-6,134
-34% -$42.5K ﹤0.01% 2365
2016
Q3 		$132K Buy
+17,783
New +$120K ﹤0.01% 2302
2015
Q4 		– Sell
-3,579
Closed -$32.3K – 3757
2015
Q3 		$50K Buy
+3,579
New +$56.1K ﹤0.01% 3287
2015
Q2 		– Sell
-18,798
Closed -$226K – 3991
2015
Q1 		$205K Sell
18,798
-170
-0.9% -$1.5K ﹤0.01% 2733
2014
Q4 		$158K Buy
18,968
+6,708
+55% +$46K ﹤0.01% 3047
2014
Q3 		$73K Buy
+12,260
New +$64.2K ﹤0.01% 3637

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Spot Trading's FOLD Position: Q3 2017 in Review

Spot Trading increased its Amicus Therapeutics (FOLD) stake by 57% in Q3 2017, buying an estimated $75.2K and bringing the position to 15,578 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #2135.

Spot Trading first reported a position in FOLD in Q3 2014 and has held it in 8 quarters since. 186 funds tracked by Wall St. Rank hold FOLD as of Q3 2017.

  • Spot Trading held 15,578 shares of Amicus Therapeutics worth $235K as of Q3 2017.
  • Spot Trading bought 5,686 Amicus Therapeutics shares in Q3 2017, an estimated $75.2K.
  • Amicus Therapeutics made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2135 holding.
  • Spot Trading first reported a position in Amicus Therapeutics in Q3 2014 and has held it in 8 quarters since.
  • 186 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.